CAROL CAMERON-MATTHEWS: Open Payments
NPI 1326541574 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,730 in 170 payments from 16 companies in 2025. Trend: 2023 $2,311 · 2024 $2,797 · 2025 $3,730
Food & beverage: $3,618Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 16 | $612 |
| Otsuka America Pharmaceutical, Inc. | 22 | $462 |
| Vanda Pharmaceuticals Inc. | 21 | $437 |
| E.R. Squibb & Sons, L.L.C. | 19 | $337 |
| ABBVIE INC. | 18 | $295 |
| Alkermes, Inc. | 12 | $288 |
| Janssen Pharmaceuticals, Inc | 7 | $276 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $267 |
| Almatica Pharma LLC | 14 | $216 |
| Axsome Therapeutics, Inc. | 8 | $173 |
Products named: FANAPT, REXULTI, AUSTEDO XR, COBENFY, VRAYLAR, INVEGA SUSTENNA, CAPLYTA, ARISTADA.
Industry payments across NC — which companies pay providers there.
